‘Subdued prescriber activity’ blamed by Cann Group for revenue fall by Steve Jones March 2, 2026March 5, 2026 The health regulator’s review of medicinal cannabis led to “subdued prescriber activity” towards the end of […]
Cann Group set for ‘stronger future’ after ‘challenging period’, outgoing chair tells shareholders by Steve Jones December 4, 2025February 21, 2026
Cann Group halves FY25 loss as flower output climbs while oil falls by Adam Sheldon September 1, 2025September 1, 2025
Cann Group expecting cash flow improvement but revenue falls 25% by Steve Jones April 30, 2025April 30, 2025
Cann Group goes back to investors in bid to raise $6.25m for product expansion by Steve Jones October 8, 2024October 8, 2024
Cann Group outlines ‘investment opportunity’ with four-year growth plan and Mildura expansion by Steve Jones July 25, 2024July 25, 2024
Cann Group secures additional funding, reissues half-year results by Steve Jones May 9, 2024July 16, 2024
Cann Group takes steps to resume ASX trading as Q3 revenues tumble and cash flow worsens by Steve Jones April 30, 2024April 30, 2024
